Exclusive analysis of biotech, pharma, and the life sciences
In-depth analysis of biotech, pharma, and the life sciences
from some of the nation's most trusted and well-connected reporters in the industry
with STAT+ reporters and leading industry experts in our STAT+ Conversations series
hosted by STAT+, plus early-bird access and discounts to industry events around the country
get delivered to your inbox to brief you on the most important industry news of the day
like our CRISPR Trackr and Drug Pricing Policy Tracker
In-depth analysis of biotech, pharma, and the life sciences
from some of the nation's most trusted and well-connected reporters in the industry
with STAT+ reporters and leading industry experts in our STAT+ Conversations series
hosted by STAT+, plus early-bird access and discounts to industry events around the country
get delivered to your inbox to brief you on the most important industry news of the day
like our CRISPR Trackr and Drug Pricing Policy Tracker
W ASHINGTON — As the U.S. health system buckles under the weight of the Covid-19 pandemic, private equity firms are cashing in.
Some of their investments center on nurse staffing agencies, a little-known cluster of companies that send free-floating nurses to help hospitals when they’re short-staffed or otherwise in need of extra assistance. Hospitals have relied on the agencies like never before during the pandemic, as wave after wave of hospitalizations strained nurses, who face a crushing burden of sick patients and the possibility that they will fall ill themselves.
Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!
Rachel reports on the intersection of politics and health policy.
This name will appear with your comment
There was an error saving your display name. Please check and try again.
Reporting from the frontiers of health and medicine
You've been selected! Subscribe to STAT+ for less than $2 per day
Unlimited access to essential biotech, medicine, and life sciences journalism
Subscribe to STAT+ for less than $2 per day
Unlimited access to the health care news and insights you need